A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis
Methodological detailsposition paper
- Position paper
Recommendations
As issued by the authors
Integrate clinical, genetic, biochemical, radiological, pathological and molecular information for all adenomas from anterior pituitary cell lineages to guide prognosis and therapy
Use evidence-based scoring of risk factors to give a cumulative score that reflects disease severity and can be used at the bedside to guide pituitary adenoma management
Original publication
A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis. Lancet Diabetes Endocrinol. Published 29 January 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →